N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Ferraris, Jimena ^a   Radl, Daniela Betiana ^a   Zárate, Sandra ^a   Jaita, Gabriela ^a   Eijo, Guadalupe ^a   Zaldivar, Verónica ^a   Clapp, Carmen ^b   Seilicovich, Adriana ^a   Pisera, Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FORSKOLIN; PROLACTIN DERIVATIVE; UNCLASSIFIED DRUG; VASOINHIBIN; PEPTIDE FRAGMENT; PROLACTIN;

ADENOHYPOPHYSIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FLOW CYTOMETRY; HORMONAL REGULATION; HORMONE SYNTHESIS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; NICK END LABELING; NONHUMAN; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; RAT; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ESTRUS; METABOLISM; MOLECULAR WEIGHT; SECRETION; WISTAR RAT;

RATTUS;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ESTRADIOL; ESTRUS; FEMALE; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RATS, WISTAR;

EID: 79960053517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021806     Document Type: Article

References (31)

1. Yin P, Arita J, (2002) Proestrus surge of Gonadotropin-releasing hormone secretion inhibits apoptosis of anterior pituitary cells in cycling female rats. Neuroendocrinology 76: 272-282.
2. Hashi A, Mazawa S, Chen S, Kato J, Arita J, (1995) Pentobarbital anesthesia during the proestrous afternoon blocks lactotroph proliferation occurring on estrus in female rats. Endocrinology 136: 4665-4671.
3. Candolfi M, Zaldivar V, De Laurentiis A, Jaita G, Pisera D, et al. (2002) TNF-alpha induces apoptosis of lactotropes from female rats. Endocrinology 143: 3611-3617.
4. Jaita G, Candolfi M, Zaldivar V, Zárate S, Ferrari L, et al. (2005) Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotrophs. Endocrinology 146: 4737-4744.
5. Radl DB, Zárate S, Jaita G, Ferraris J, Zaldivar V, et al. (2008) Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. Neuroendocrinology 88: 43-52.
6. Zárate S, Jaita G, Zaldivar V, Radl DB, Eijo G, et al. (2009) Estrogens exert a rapid apoptotic action in anterior pituitary cells. Am J Physiol Endocrinol Metab 206: E664-671.
7. Zárate S, Zaldivar V, Jaita G, Magri L, Radl D, et al. (2010) Role of estrogens in anterior pituitary gland remodeling during the estrous cycle. Front Horm Res 38: 25-31.
8. Freeman ME, Kanyicsa B, Lerant A, Nagy G, (2000) Prolactin: Structure, function and regulation of secretion. Physiol Rev 80: 1523-1631.
9. Sinha YN, (1995) Structural variants of Prolactin: Occurrence and physiological significance. Endocr Rev 16: 354-369.
10. Clapp C, Aranda J, González C, Jeziorski MC, Martínez de la Escalera G, (2006) Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol Metab 17: 301-307.
11. Tabruyn SP, Nguyen N, Cornet A, Martial J, Struman I, (2005) The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases. Mol Endocrinol 19: 1932-1942.
12. Martini J, Piot C, Humeaut L, Struman I, Martial J, et al. (2000) The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation. Mol Endocrinol 14: 1536-1549.
13. Tabruyn SP, Sorlet CM, Rentier-Delrue S, Bours V, Weiner R, et al. (2005) The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB. Mol Endocrinol 17: 1815-1823.
14. Cruz-Souto ME, Cosio G, Jeziorski MC, Vargas-Barroso V, Aguilar MB, et al. (2009) Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules. Endocrinology 150: 5446-5454.
15. Clapp C, Martial JA, Guzman R, Retier-Delrue F, Weiner R, (1993) The 16-kilodalton N-terminal fragment of Human Prolactin is a potent inhibitor of angiogenesis. Endocrinology 133: 1292-1299.
16. Suzuki S, Yamamoto I, Arita J, (1999) Mitogen-activated protein kinase-dependent stimulation of proliferation of rat lactotrophs in culture by 3′,5′-cyclic adenosine monophosphate. Endocrinology 140: 2850-2858.
17. Galfione M, Luo W, Kim J, Hawke D, Kobayashi R, et al. (2003) Expression and purification of the angiogenesis inhibitor 16 kDa prolactin fragment form insect cells. Protein Expr Purif 28: 252-258.
18. Pisera D, Candolfi M, Navarra S, Ferraris J, Zaldivar V, et al. (2004) Estrogens sensitize anterior pituitary gland to apoptosis. Am J Physiol Endocrinol Metab 287: E767-771.
19. Zaldivar V, Magri ML, Zárate S, Jaita G, Eijo G, et al. (2009) Estradiol increases the Bax/Bcl-2 ratio and induces apoptosis in the anterior pituitary gland. Neuroendocrinology 90: 292-300.
20. Ge G, Fernandez C, Moses MA, Greenspan DS, (2007) Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. Proc Natl Acad Sci USA 104: 10010-10015.
21. Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, et al. (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett 237: 167-179.
22. Lkhider M, Castino R, Bouguyon E, Isidoro C, Ollivier-Bousquet M, (2004) Cathepsin D released by lactating mammary epitelial cells involved in prolactin cleavage under physiological conditions. J Cell Sci 117: 5155-5164.
23. Erdmann S, Ricken A, Merkwitz C, Struman I, Castino R, et al. (2007) The expression of prolactin and its cathepsin D-mediated cleavage in bovine corpus luteum vary with the estrous cycle. Am J Physiol Endocrinol Metab 293: E1365-E1377.
24. Castino R, Depal S, Bouguyon E, Demoz M, Isidoro C, et al. (2008) Prolactin promotes the secretion of active cathepsin D at the basal side of the rat mammary acini. Endocrinology 149: 4095-4105.
25. Piwnica D, Fernandez I, Binart N, Touraine P, Kelly P, et al. (2006) A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol 20: 3236-3278.
26. Piwnica D, Touraine P, Struman I, Tabruyn S, Bolbach G, et al. (2004) Cathepsin D processes human prolactin into multiple 16K-like N-terminal Fragments: study of their antiangiogenic properties and physiological relevance. Mol Endocrinol 18: 2522-2542.
27. Andries M, Tilemans D, Denef C, (1992) Isolation of cleaved prolactin variants that stimulate DNA synthesis in specific cell types in rat pituitary cell aggregates in culture. Biochem J 281: 393-400.
28. Elangovan S, Moulton B, (1980) Progesterone and estrogen control of rates of synthesis of uterine cathepsin D. J Biol Chem 255: 7474-7479.
29. Rochefort H, Chalbos D, Cunat S, Lucas A, Platet N, et al. (2001) Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells. J Steroid Biochem Mol Biol 76: 119-124.
30. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, et al. (2000) Angiogenesis in pituitary adenomas and normal pituitary gland. J Clin Endocrinol Metab 85: 131-139.
31. Méndez I, Vega C, Zamorano M, Moreno-Carranza B, Martínez de la Escalera G, et al. (2010) Vasoinhibins and the Pituitary Gland. Front Horm Res 38: 184-189.